Ameritas Investment Partners’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-396
| Closed | -$3.41K | – | 3288 |
|
|
2025
Q1 | $3.41K | Hold |
396
| – | – | ﹤0.01% | 3029 |
|
|
2024
Q4 | $14.2K | Hold |
396
| – | – | ﹤0.01% | 2780 |
|
|
2024
Q3 | $18.7K | Hold |
396
| – | – | ﹤0.01% | 2694 |
|
|
2024
Q2 | $19.9K | Hold |
396
| – | – | ﹤0.01% | 2616 |
|
|
2024
Q1 | $44.3K | Hold |
396
| – | – | ﹤0.01% | 2218 |
|
|
2023
Q4 | $23K | Hold |
396
| – | – | ﹤0.01% | 2522 |
|
|
2023
Q3 | $12.6K | Buy |
396
+113
| +40% | +$5.37K | ﹤0.01% | 2731 |
|
|
2023
Q2 | $23.3K | Hold |
283
| – | – | ﹤0.01% | 2489 |
|
|
2023
Q1 | $29K | Hold |
283
| – | – | ﹤0.01% | 2292 |
|
|
2022
Q4 | $46.1K | Hold |
283
| – | – | ﹤0.01% | 2108 |
|
|
2022
Q3 | $47K | Buy |
283
+67
| +31% | +$10.9K | ﹤0.01% | 2024 |
|
|
2022
Q2 | $24K | Hold |
216
| – | – | ﹤0.01% | 2463 |
|
|
2022
Q1 | $22K | Hold |
216
| – | – | ﹤0.01% | 2519 |
|
|
2021
Q4 | $34K | Hold |
216
| – | – | ﹤0.01% | 2372 |
|
|
2021
Q3 | $51K | Hold |
216
| – | – | ﹤0.01% | 2145 |
|
|
2021
Q2 | $73K | Buy |
216
+35
| +19% | +$13.3K | ﹤0.01% | 1932 |
|
|
2021
Q1 | $73K | Hold |
181
| – | – | ﹤0.01% | 1851 |
|
|
2020
Q4 | $121K | Hold |
181
| – | – | 0.01% | 1460 |
|
|
2020
Q3 | $84K | Buy |
181
+19
| +12% | +$9.6K | ﹤0.01% | 1543 |
|
|
2020
Q2 | $95K | Buy |
162
+42
| +35% | +$14.3K | ﹤0.01% | 1443 |
|
|
2020
Q1 | $18K | Hold |
120
| – | – | ﹤0.01% | 2238 |
|
|
2019
Q4 | $17K | Hold |
120
| – | – | ﹤0.01% | 2484 |
|
|
2019
Q3 | $5K | Buy |
120
+82
| +216% | +$5.96K | ﹤0.01% | 2934 |
|
|
2019
Q2 | $4K | Hold |
38
| – | – | ﹤0.01% | 2966 |
|
|
2019
Q1 | $5K | Hold |
38
| – | – | ﹤0.01% | 2860 |
|
|
2018
Q4 | $4K | Hold |
38
| – | – | ﹤0.01% | 2887 |
|
|
2018
Q3 | $9K | Hold |
38
| – | – | ﹤0.01% | 2865 |
|
|
2018
Q2 | $17K | Hold |
38
| – | – | ﹤0.01% | 2596 |
|
|
2018
Q1 | $15K | Buy |
38
+25
| +192% | +$9.87K | ﹤0.01% | 2557 |
|
|
2017
Q4 | $5K | Buy |
+13
| New | +$5.67K | ﹤0.01% | 2871 |
|
Other funds holding MRSN
NI
BCLSI
SSA
RSCM
SCM